The Gleevec story: Fifteen years later
Fifteen years ago, an astounding breakthrough changed the way the world treats cancer. The discovery by Brian Druker, M.D., now director of the OHSU Knight Cancer Institute, turned chronic myeloid leukemia (CML) from a deadly disease with a very short life expectancy into a treatable condition managed by a daily pill, called Gleevec. It was […]